HETERO LABS LTD FDA Approval ANDA 213034

ANDA 213034

HETERO LABS LTD

FDA Drug Application

Application #213034

Application Sponsors

ANDA 213034HETERO LABS LTD

Marketing Status

Prescription001

Application Products

001TABLET;ORAL-283MG;0.03MG0DROSPIRENONE AND ETHINYL ESTRADIOLDROSPIRENONE; ETHINYL ESTRADIOL

FDA Submissions

UNKNOWN; ORIG1AP2020-01-24STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

HETERO LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213034
            [companyName] => HETERO LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"DROSPIRENONE AND ETHINYL ESTRADIOL","activeIngredients":"DROSPIRENONE; ETHINYL ESTRADIOL","strength":"3MG;0.03MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/24\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-01-24
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.